AVTX: Rega marang dodolan Avalo Therapeutics, Inc.

Simbol lan logo merek Avalo Therapeutics Inc. (AVTX)

Developing therapies for immune pathologies requires massive investment, as evidenced by the price-to-sales ratio chart. The value of 7035.20 represents the current level of this metric. To combat funding shortages, Avalo Therapeutics, Inc (AVTX) is restructuring its asset portfolio. Future success depends on FDA approval of its patent-protected monoclonal antibodies, which will enable the treatment of severe systemic inflammation.

Kapitalisasi marang pendapatan: avalotx.com (AVTX) kanggo 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Avalo Therapeutics, Inc (AVTX)

Analisis fundamental perusahaan:AVTX - Avalo Therapeutics Inc.
Produk mawa merek Avalo Therapeutics Inc

The P/S multiple reflects the market value of a business relative to its annual revenue, allowing for an assessment of the premium paid per unit of income. For Avalo Therapeutics, Inc (AVTX), whose success depends on FDA approval of monoclonal antibodies, the company's P/S chart serves as an indicator of speculative expectations, where deviations from historical averages signal risks of overvaluing the potential of future patents.

Karo sapa Avalo Therapeutics, Inc saingan

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|Kapitalisasi marang pendapatan Eledon Pharmaceuticals ELDN|Rasio rega marang pendapatan Agenus, Inc. AGEN|Multiplikator P/S Climb Bio Inc. CLYM|ZURA - Rasio rega marang pendapatan|Rasio rega marang dodolan ATYR|ADAG (Adagene Inc.) - Kapitalisasi marang pendapatan|ImageneBio Inc (IMA) - Multiplikator P/S|Rasio rega marang pendapatan Shattuck Therapeutics|Kapitalisasi marang pendapatan equilliumbio.com (EQ)|Multiplikator P/S CNTB|Koefisien rega marang pendapatan Immunic Therapeutics|Multiplikator P/S ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Rasio kapitalisasi marang pendapatan|CELU: Multiplikator P/S|INMB - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Barinthus Biotherapeutics plc|KZR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SABS|AKTX (Akari Therapeutics Plc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Rasio rega marang pendapatan|GOVX: Kapitalisasi marang pendapatan|edesabiotech.com (EDSA) - Kapitalisasi marang pendapatan|IBIO: Multiplikator P/S|CARM - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan XTLB|Kapitalisasi marang pendapatan boltbio.com (BOLT)|Rasio rega marang pendapatan HCW Biologics Inc (HCWB)|Multiplikator P/S Aptevo Therapeutics, Inc. (APVO)|Rasio rega marang pendapatan aimimmuno.com AIM|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio Corporation - Multiplikator P/S|XORTX Corp (XRTX) - Kapitalisasi marang pendapatan|HIND (Vyome Holdings Inc.) - Kapitalisasi marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S